Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis - Divided Values

Type II network, divided values. Interestingly most of the proteins in the first 100 positions in this table would occur in the divided ranks table between position 100 and 200, indicating a difference in emphasis between the two simulations but not in the overall function. The fully annotated table, include Ensembl gene identifiers and network values can be found in the supplementary data.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank description Gene Value Type Network Comparison Type Interaction Map Filtered green red network_comparison
Results: HTML CSV LaTeX Showing element 51 to 100 of 7460 in total 
Value Type: Measured
Interaction Map: High confidence

\def\wcA{0.125\textwidth}
\def\wcB{0.125\textwidth}
\def\wcC{0.125\textwidth}
\def\wcD{0.125\textwidth}
\def\wcE{0.125\textwidth}
\def\wcF{0.125\textwidth}
\def\wcG{0.125\textwidth}
\begin{longtable}{|c|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Network Comparison Type\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Filtered\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
13\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cytoplasmic polyadenylation element binding protein 3. [source:refseq;acc:nm\_014912]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
1\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
1281.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
398.5\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
3.21581\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
myosin vb (myosin 5b) (fragment). [source:swissprot;acc:q9ulv0]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&&\parbox{\wcE}{\vspace{3pt}\noindent
27904.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
21591.5\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
6313\vspace{3pt}}\\\cline{1-2}\cline{4-7}
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
14\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
apoptosis inhibitor fksg2. [source:swissprot;acc:q9hau6]\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
12125.1\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
10817.1\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1308\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
cyclin h (mo15-associated protein) (p37) (p34). [source:swissprot;acc:p51946]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
6.50325\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
130.512\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
20.0687\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
myosin vc (myosin 5c). [source:swissprot;acc:q9nqx4]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
1\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
27904.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
21591.5\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
6313\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
ras gtpase-activating protein ngap (ras protein activator like 1). [source:swissprot;acc:q9ujf2]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
1281.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
398.5\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
3.21581\vspace{3pt}}\\\cline{1-3}\cline{5-7}
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
15\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
myosin va (myosin 5a) (dilute myosin heavy chain, non-muscle) (myosin heavy chain 12) (myoxin). [source:swissprot;acc:q9y4i1]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
27904.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
21591.5\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
6313\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial precursor (cybs) (succinate-ubiquinone reductase membrane anchor subunit) (qps2) (cii-4) (succinate dehydrogenase complex subunit d) (succinate-ubiquinone oxidoreductase cytochrome b small subunit). [source:swissprot;acc:o14521]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
156\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
10\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
15.6\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
ubiquitin-like protein smt3b (sentrin 2) (hsmt3). [source:swissprot;acc:p55855]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
6685.11\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
7981.68\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1296.57\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
xpa binding protein 1; mbd2 interactor protein; putative atp(gtp)-binding protein. [source:refseq;acc:nm\_007266]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
1\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
871\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
2671\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
3.06659\vspace{3pt}}\\\cline{1-3}\cline{5-7}
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
16\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cysteine endopeptidase aut-like 2 isoform a; autophagy-related cysteine endopeptidase 2; autophagin 2. [source:refseq;acc:nm\_052936]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&&\parbox{\wcE}{\vspace{3pt}\noindent
18172.1\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
24260.3\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
6088.2\vspace{3pt}}\\\cline{2-2}\cline{4-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
nif3-like protein 1 (amyotrophic lateral sclerosis 2 chromosomal region candidate gene protein 1) (my018 protein) (mds015). [source:swissprot;acc:q9gzt8]\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
7572.88\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
8852.4\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1279.52\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
protein transport protein sec24c (sec24-related protein c). [source:swissprot;acc:p53992]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&&\parbox{\wcE}{\vspace{3pt}\noindent
15\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
15\vspace{3pt}}\\\cline{2-2}\cline{4-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
protein x 0004. [source:refseq;acc:nm\_016301]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
871\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
2671\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
3.06659\vspace{3pt}}\\\hline
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
17\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
ba271b5.1 (similar to ribosomal protein s7). [source:sptrembl;acc:q9h1s9]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
12473\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
11223\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1250\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
dgcr14 protein (digeorge syndrome critical region 14) (es2 protein). [source:swissprot;acc:q96df8]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
1\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
1365\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
460\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
2.96739\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
microtubule-associated proteins 1a/1b light chain 3b (map1a/map1b lc3 b) (map1a/1b light chain 3 b). [source:swissprot;acc:q9gzq8]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
18168.9\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
24255.7\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
6086.8\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
mln 64 protein (star-related lipid transfer protein 3) (stard3) (start domain-containing protein 3) (cab1 protein). [source:swissprot;acc:q14849]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
58\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
859\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
14.8103\vspace{3pt}}\\\cline{1-2}\cline{5-7}
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
18\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
60s ribosomal protein l37a. [source:swissprot;acc:p12751]\vspace{3pt}}&&&\parbox{\wcE}{\vspace{3pt}\noindent
26.1599\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
305.45\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
11.6763\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
anaphase promoting complex subunit 11 (hepatocellular carcinoma associated ring finger protein) (hspc214). [source:swissprot;acc:q9nyg5]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&&\parbox{\wcE}{\vspace{3pt}\noindent
14167\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
15411.3\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1244.3\vspace{3pt}}\\\cline{2-2}\cline{4-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
microtubule-associated proteins 1a/1b light chain 3a (map1a/map1b lc3 a) (map1a/1b light chain 3 a). [source:swissprot;acc:q9h492]\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
1\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
18168.9\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
24255.7\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
6086.8\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
protein phosphatase 1, regulatory (inhibitor) subunit 14a; 17-kda pkc-potentiated inhibitory protein of pp1. [source:refseq;acc:nm\_033256]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&&\parbox{\wcE}{\vspace{3pt}\noindent
1865.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
677.5\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
2.75351\vspace{3pt}}\\\cline{1-2}\cline{4-7}
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
19\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
25-hydroxyvitamin d-1 alpha hydroxylase, mitochondrial precursor (ec 1.14.-.-) (25-ohd-1 alpha-hydroxylase) (25-hydroxyvitamin d3 1- alpha-hydroxylase) (vd3 1a hydroxylase) (p450c1 alpha) (p450vd1- alpha). [source:swissprot;acc:o15528]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
26.1599\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
305.45\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
11.6763\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
cysteine endopeptidase aut-like isoform b. [source:refseq;acc:nm\_178326]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
18164.9\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
24250\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
6085.1\vspace{3pt}}\\\cline{2-2}\cline{4-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
dj570f3.6 (novel protein similar to lysophospholipase ii (lypla2)). [source:sptrembl;acc:q9uge0]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2804\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1593\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1211\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
microfibril-associated glycoprotein 4 precursor. [source:swissprot;acc:p55083]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1865.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
677.5\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
2.75351\vspace{3pt}}\\\cline{1-2}\cline{4-7}
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
20\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
ero1-like. [source:refseq;acc:nm\_014584]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
82\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
8200000\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
gaba(a) receptor-associated protein; gaba(a)-receptor-associated protein. [source:refseq;acc:nm\_007278]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
17580.4\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
23421.5\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
5841.1\vspace{3pt}}\\\cline{2-2}\cline{4-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
polyadenylate-binding protein 3 (poly(a)-binding protein 3) (pabp 3) (testis-specific poly(a)-binding protein). [source:swissprot;acc:q9h361]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7608\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
8763\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1155\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
protein phosphatase 1, regulatory subunit 14d; pkc-dependent pp1 inhibitory protein. [source:refseq;acc:nm\_017726]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
1\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1865.5\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
677.5\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcG}{\vspace{3pt}\noindent
2.75351\vspace{3pt}}}\\\cline{1-2}
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
21\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
ficolin 2 precursor (collagen/fibrinogen domain-containing protein 2) (ficolin-b) (ficolin b) (serum lectin p35) (ebp-37) (hucolin) (l- ficolin). [source:swissprot;acc:q15485]\vspace{3pt}}&&&&&\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
melanoma antigen, family d, 4 isoform 1; mage1 protein; mage-e1 protein; maged4 protein. [source:refseq;acc:nm\_030801]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&&\parbox{\wcE}{\vspace{3pt}\noindent
18263\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
23693.7\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
5430.7\vspace{3pt}}\\\cline{2-2}\cline{4-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
swi/snf related, matrix associated, actin dependent regulator of chromatin subfamily d member 1 (swi/snf complex 60 kda subunit) (brg1- associated factor 60a). [source:swissprot;acc:q96gm5]\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
5690.63\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
6804.88\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1114.25\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
syntaxin 10 (syn10). [source:swissprot;acc:o60499]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
17.6611\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
118.878\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
6.73106\vspace{3pt}}\\\hline
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
22\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
hepatocellular carcinoma-associated protein hca3. [source:refseq;acc:nm\_138703]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
1\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
18263\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
23693.7\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
5430.7\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
protein phosphatase 1, regulatory (inhibitor) subunit 14c; serologically defined breast cancer antigen ny-br-81; pkc-potentiated pp1 inhibitory protein. [source:refseq;acc:nm\_030949]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&&\parbox{\wcE}{\vspace{3pt}\noindent
1865.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
677.5\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
2.75351\vspace{3pt}}\\\cline{2-2}\cline{4-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
similar to lysozyme c-1 (1,4-beta-n-acylmuramidase c, ec 3.2.1.17). [source:refseq;acc:nm\_032517]\vspace{3pt}}&&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
60\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
6000000\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
transcription initiation factor tfiid 135 kda subunit (tafii-135) (tafii135) (tafii-130) (tafii130). [source:swissprot;acc:o00268]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&&\parbox{\wcE}{\vspace{3pt}\noindent
30022.4\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
31122\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1099.6\vspace{3pt}}\\\cline{1-2}\cline{5-7}
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
23\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
fructose-1,6-bisphosphatase isozyme 2 (ec 3.1.3.11) (d-fructose-1,6- bisphosphate 1-phosphohydrolase) (fbpase). [source:swissprot;acc:o00757]\vspace{3pt}}&&&\parbox{\wcE}{\vspace{3pt}\noindent
5540.2\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
6596.23\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1056.03\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
gbp protein isoform a. [source:refseq;acc:nm\_017870]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1894.39\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
699.76\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
2.7072\vspace{3pt}}\\\cline{2-2}\cline{4-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
guanine nucleotide-binding protein beta subunit-like protein 1 (g protein beta-subunit like protein 1) (wd40 repeat containing protein deleted in vcfs) (wdvcf protein) (fksg1 protein) (dgcrk3). [source:swissprot;acc:q9byb4]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
59\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
5900000\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
melanoma-associated antigen 3 (mage-3 antigen) (antigen mz2-d). [source:swissprot;acc:p43357]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
18263\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
23693.7\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
5430.7\vspace{3pt}}\\\cline{1-2}\cline{4-7}
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
24\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
fos-related antigen 2. [source:swissprot;acc:p15408]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2208.1\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
3233.86\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1025.76\vspace{3pt}}\\\cline{2-2}\cline{4-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
melanoma-associated antigen 11 (mage-11 antigen). [source:swissprot;acc:p43364]\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
1\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
18263\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
23693.7\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
5430.7\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
protein kinase, interferon-inducible double stranded rna dependent activator; protein activator of the interferon-induced protein kinase. [source:refseq;acc:nm\_003690]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&&\parbox{\wcE}{\vspace{3pt}\noindent
2108.52\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
950.561\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
2.21818\vspace{3pt}}\\\cline{2-2}\cline{4-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
ptd016 protein. [source:refseq;acc:nm\_016125]\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
158\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
30\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
5.26667\vspace{3pt}}\\\cline{1-3}\cline{5-7}
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
25\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
adp,atp carrier protein, liver isoform t2 (adp/atp translocase 3) (adenine nucleotide translocator 3) (ant 3). [source:swissprot;acc:p12236]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
1377\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
459.5\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
917.5\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
guanine nucleotide-binding protein g(i)/g(s)/g(o) gamma-7 subunit. [source:swissprot;acc:o60262]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
1\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
892.67\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1833.01\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
2.0534\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
melanoma-associated antigen 2 (mage-2 antigen). [source:swissprot;acc:p43356]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
18263\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
23693.7\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
5430.7\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
potential phospholipid-transporting atpase iia (ec 3.6.1.-). [source:swissprot;acc:o75110]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
773\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
148\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
5.22297\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/